Why Sponsor Eye Believe? Your sponsorship is more than a logo—it’s a lifeline. Eye Believe is one of the few nationwide events dedicated exclusively to patients living with ocular melanoma. It offers medical insight, emotional strength, and a renewed outlook on life. By partnering with us, you help ensure this event remains accessible to all, [...]
2025 Rare Disease Day, Hill Day and MRA Scientific Meeting
A Cure In Sight celebrated rare disease week in Washington DC and Boston MA. We had a great group of ocular melanoma patients and supports join ACIS and Everylife Foundation for a great 2 days at Capital Hill. In person meetings were held with Representatives and Senators from Rhode Island, Virginia, Pennsylvania, North Carolina [...]
Faces of ocular melanoma 2025
Your Content Goes Here
ESMO Recap
ACIS at the European Society for Medical Oncology (ESMO) Annual Congress ACIS’s Research Coordinator (Kevin) collected clinical data from uveal melanoma sessions at ESMO (reported below), and met with Patient Advocates from Germany, Slovenia, Ireland, [...]
Meet Arjun Pediatric Ocular Melanoma Survivor
Meet Arjun, Pediatric Ocular Melanoma Arjun was diagnosed as a baby with #ocularmelanoma making him one of the rarest in our rare cancer community. When asked what the hardest parts of navigating a pediatric cancer diagnosis as a family was, his mother Sumathy shared: "I find I struggle with having a child with cancer. [...]
Rare Disease Day – Ocular Melanoma Stories
Celebrating Life Beyond Ocular Melanoma: Tricia's 19-Year Journey In the spring of 2005, Tricia's routine eye examination uncovered something life-altering. At 46, a day that began with the simple intent to get reading glasses led to a diagnosis of ocular melanoma. Facing the unknown with her family by her side, Tricia's resilience shone [...]
5Ks in Florida 2024
Steps for Sight - donate and register here This past weekend, starting in Orlando and finishing in sunny Miami, we hosted 2 Lookin' For a Cure 5ks - our first of the new year! Thank you to all who came out in support-- from patients to caregivers, and a huge thanks to the Bascom [...]
iOnctura Clinical Trial News
IOnctura Announces FDA Clearance Of IND Application For Roginolisib, A First-In-Class Allosteric Modulator Of PI3Kδ This FDA clearance will allow IOnctura to continue with a clinical trial in the United States. Read more here! READ MORE
Improved prediction of Metastasis using Tumor Volume
Enhanced Staging of Choroidal Melanomas and Ciliary Body: Tumor Volume Estimation and Competing Risk Analyses The current model for staging is developed using tumor size alone. A retroactive study was done to develop a new model for staging and prediction of disease progression. Researchers treated 6,528 consecutively registered patients at three tertiary ocular oncology centers [...]
ACIS and Rachael and Chris Horn are crating the first OMie cookbook. Be apart of this great project and add a recipe your recipe (or a few) and be featured in this cookbook. We'll have available to purchase in person/in our store at the Eye Believe Surviorship Seminar in Seattle Washington! Check out our events [...]








